Insider Trading History of Haqq Christopher


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Haqq Christopher since year 2005. The trader's CIK number is 1612095. At the time of the last reporting, Haqq Christopher was the Chief Medical Officer of Atara Biotherapeutics, Inc. . (stock ticker symbol ATRA). See this page for all insider trading activities at Atara Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Haqq Christopher since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-15 ATRA Atara Biotherapeutics, Inc. Sale 775 39.59 30,682
2019-02-11 ATRA Atara Biotherapeutics, Inc. Sale 13,975 38.55 538,736
2019-02-06 ATRA Atara Biotherapeutics, Inc. Sale 12,375 38.41 475,323
2018-11-15 ATRA Atara Biotherapeutics, Inc. Sale 775 33.81 26,202
2018-09-26 ATRA Atara Biotherapeutics, Inc. Sale 13,500 43.08 581,580
2018-09-25 ATRA Atara Biotherapeutics, Inc. Sale 13,500 40.74 550,057
2018-09-24 ATRA Atara Biotherapeutics, Inc. Sale 18,000 40.13 722,430
2018-08-15 ATRA Atara Biotherapeutics, Inc. Sale 775 37.54 29,093
2018-05-15 ATRA Atara Biotherapeutics, Inc. Sale 25,775 45.22 1,165,622
2018-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 25,000 11.00 275,000
2018-03-26 ATRA Atara Biotherapeutics, Inc. Sale 18,327 40.02 733,538
2018-02-15 ATRA Atara Biotherapeutics, Inc. Option Ex 553 .00 0
2017-11-15 ATRA Atara Biotherapeutics, Inc. Sale 1,604 13.36 21,429
2017-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2017-10-16 ATRA Atara Biotherapeutics, Inc. Sale 6,000 14.35 86,100
2017-09-15 ATRA Atara Biotherapeutics, Inc. Sale 6,000 15.30 91,800
2017-08-15 ATRA Atara Biotherapeutics, Inc. Sale 7,604 14.75 112,159
2017-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2017-07-17 ATRA Atara Biotherapeutics, Inc. Sale 6,000 14.92 89,520
2017-06-15 ATRA Atara Biotherapeutics, Inc. Sale 6,000 12.65 75,900
2017-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2017-05-15 ATRA Atara Biotherapeutics, Inc. Sale 7,604 14.99 113,983
2017-04-17 ATRA Atara Biotherapeutics, Inc. Sale 6,000 17.28 103,680
2017-03-15 ATRA Atara Biotherapeutics, Inc. Sale 6,000 19.60 117,600
2017-02-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2017-02-15 ATRA Atara Biotherapeutics, Inc. Sale 7,604 15.49 117,785
2017-02-09 ATRA Atara Biotherapeutics, Inc. Sale 13,975 15.46 216,053
2017-01-17 ATRA Atara Biotherapeutics, Inc. Sale 6,000 14.27 85,620
2016-12-15 ATRA Atara Biotherapeutics, Inc. Sale 6,000 15.40 92,400
2016-11-21 ATRA Atara Biotherapeutics, Inc. Sale 7,068 17.85 126,163
2016-11-15 ATRA Atara Biotherapeutics, Inc. Sale 1,604 19.95 31,999
2016-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2016-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2016-08-15 ATRA Atara Biotherapeutics, Inc. Sale 1,346 22.14 29,800
2016-05-16 ATRA Atara Biotherapeutics, Inc. Sale 1,605 15.57 24,989
2016-05-16 ATRA Atara Biotherapeutics, Inc. Option Ex 830 .00 0
2016-02-16 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2016-02-16 ATRA Atara Biotherapeutics, Inc. Sale 3,208 15.43 49,499
2015-11-16 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2015-08-31 ATRA Atara Biotherapeutics, Inc. Sale 5,000 41.85 209,274
2015-08-17 ATRA Atara Biotherapeutics, Inc. Sale 1,604 46.16 74,048
2015-08-17 ATRA Atara Biotherapeutics, Inc. Option Ex 829 .00 0
2015-07-31 ATRA Atara Biotherapeutics, Inc. Sale 2,500 55.43 138,575
2015-07-15 ATRA Atara Biotherapeutics, Inc. Sale 2,500 63.06 157,650
2015-07-01 ATRA Atara Biotherapeutics, Inc. Sale 2,500 51.65 129,125
2015-06-15 ATRA Atara Biotherapeutics, Inc. Sale 7,500 46.08 345,600
2015-06-01 ATRA Atara Biotherapeutics, Inc. Sale 2,500 41.77 104,425
2015-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 4,422 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haqq Christopher (Chief Medical Officer of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.